Effects of heparin and its 6-O- and 2-O-desulfated derivatives with low anticoagulant activity on proliferation of human neural stem/progenitor cells

Journal of Bioscience and Bioengineering

Volumn 100, Issue 1, 2005, Pages 54-61

  Mori, Hideki ^a   Kanemura, Yonehiro ^a,d   Onaya, Junichi ^b   Hara, Masayuki ^c   Miyake, Jun ^a   Yamasaki, Mami ^d   Kariya, Yutaka ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

^c Osaka Prefecture University   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

2 O desulfated heparin; 6 O desulfated heparin; Heparin; Human neural stem progenitor cell; Proliferation

Indexed keywords

BLOOD; CELLS; COAGULATION; DERIVATIVES; NEUROLOGY;

2-0-DESULFATED HEPARIN; 6-0-DESULFATED HEPARIN; HEPARIN; HUMAN NEURAL STEM/PROGENITOR CELLS;

POLYSACCHARIDES;

2 O DESULFATED HEPARIN; 6 O DESULFATED HEPARIN; HEPARIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NEURAL STEM CELL; STEM CELL; THROMBIN TIME; THROMBOPLASTIN TIME;

EID: 27644498518     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.100.54     Document Type: Article

References (38)

1. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M.: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848 (1991).
2. Ishihara, M., Tyrrell, D. J., Stauber, G. B., Brown, S., Cousens, L. S., and Stack, R. J.: Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J. Biol. Chem., 268, 4675-4683 (1993).
3. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., and Rapraeger, A. C.: Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem., 268, 23906-23914 (1993).
4. Ashikari, S., Habuchi, H., and Kimata, K.: Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem., 270, 29586-29593 (1995).
5. Lyon, M., Deakin, J. A., Mizuno, K., Nakamura, T., and Gallagher, J. T.: Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem., 269, 11216-11223 (1994).
6. Gordon, M. Y., Riley, G. P., Watt, S. M., and Greaves, M. F.: Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature, 326, 403-405 (1987).
7. Roberts, R., Gallagher, J., Spooncer, E., Alien, T. D., Bloomfield, F., and Dexter, T. M.: Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature, 332, 376-378 (1988).
8. Park, P. W., Reizes, O., and Bernfield, M.: Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem., 275, 29923-29926 (2000).
9. Rapraeger, A.C., Krufka, A., and Olwin, B.B.: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 252, 1705-1708 (1991).
10. Jemth, P., Kreuger, J., Kusche-Gullberg, M., Sturiale, L., Gimenez-Gallego, G., and Lindahl, U.: Biosynthetic oligo-saccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding. J. Biol. Chem., 277, 30567-30573 (2002).
11. Loo, B. M. and Salmivirta, M.: Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b. J. Biol. Chem., 277, 32616-32623 (2002).
12. Reynolds, B. A., Tetzlaff, W., and Weiss, S.: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci., 12, 4565-4574 (1992).
13. McKay, R.: Stem cells in the central nervous system. Science, 276, 66-71 (1997).
14. Gage, F. H.: Mammalian neural stem cells. Science, 287, 1433-1438(2000).
15. Armstrong, R. J., Watts, C., Svendsen, C. N., Dunnett, S. B., and Rosser, A. E.: Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant., 9, 55-64 (2000).
16. Ishibashi, S., Sakaguchi, M., Kuroiwa, T., Yamasaki, M., Kanemura, Y., Ichinose, S., Shimazaki, T., Onodera, M., Okano, H., and Mizusawa, H.: Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J. Neurosci. Res., 78, 215-223 (2004).
17. McBride, J. L., Behrstock, S. P., Chen, E. Y., Jakel, R. J., Siegel, I., Svendsen, C. N., and Kordower, J. H.: Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neural., 475, 211-219 (2004).
18. Svendsen, C. N., Caldwell, M. A., Shen, J., ter Borg, M. G., Rosser, A. E., Tyers, P., Karmiol, S., and Dunnett, S. B.: Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp. Neurol., 148, 135-146 (1997).
19. Svendsen, C. N., Clarke, D. J., Rosser, A. E., and Dunnett, S. B.: Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp. Neurol., 137, 376-388 (1996).
20. Carpenter, M. K., Cui, X., Hu, Z. Y., Jackson, J., Sherman, S., Seiger, A., and Wahlberg, L. U.: In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol, 158, 265-278 (1999).
21. Svendsen, C. N., ter Borg, M. G., Armstrong, R. J., Rosser, A. E., Chandran, S., Ostenfeld, T., and Caldwell, M. A.: A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods, 85, 141-152 (1998).
22. Kanemura, Y., Mori, H., Kobayashi, S., Islam, O., Kodama, E., Yamamoto, A., Nakanishi, Y., Arita, N., Yamasaki, M., Okano, H., Kara, M., and Miyake, J.: Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J. Neurosci. Res., 69, 869-879 (2002).
23. Vescovi, A. L., Parati, E. A., Gritti, A., Poulin, P., Ferrario, M., Wanke, E., Frolichsthal-Schoeller, P., Cova, L., Arcellana-Panlilio, M., Colombo, A., and Galli, R.: Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol., 156, 71-83 (1999).
24. Caldwell, M. A. and Svendsen, C. N.: Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells. Exp. Neurol, 152, 1-10 (1998).
25. Brannen, C. L. and Sugaya, K.: In vitro differentiation of multipotent human neural progenitors in serum-free medium. Neuroreport, 11, 1123-1128 (2000).
26. Ishihara, M., Kariya, Y., Kikuchi, H., Minamisawa, T., and Yoshida, K.: Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. (Tokyo), 121, 345-349 (1997).
27. Kariya, Y., Kyogashima, M., Suzuki, K., Isomura, T., Sakamoto, T., Horie, K., Ishihara, M., Takano, R., Kamei, K., and Hara, S.: Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor. J. Biol. Chem., 275, 25949-25958 (2000).
28. Usuki, S., Kariya, Y., Rosner, H., Ishihara, M., Sakamoto, T., Masuda, H., and Kyogashima, M.: Enhancement of neurite outgrowth-promoting activity by heparin derivatives in sodium chlorate-treated explant cultures of rat central neurons. J. Biochem. (Tokyo), 133, 783-790 (2003).
29. Kalyani, A. J., Mujtaba, T., and Rao, M. S.: Expression of EGF receptor and FGF receptor isoforms during neuroepithelial stem cell differentiation. J. Neurobiol., 38, 207-224 (1999).
30. Qian, X., Davis, A. A., Goderie, S. K., and Temple, S.: FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron, 18, 81-93 (1997).
31. Gallagher, J. T.: The extended family of proteoglycans: social residents of the pericellular zone. Curr. Opin. Cell Biol., 1, 1201-1218 (1989).
32. Ishihara, M. and Ono, K.: Structure and function of heparin and heparan sulfate; heparinoid library and modification of FGF-activities. Trends Glycosci. Glycotechnol., 10, 223-233 (1998).
33. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., and Rees, D. C.: Heparin structure and interactions with basic fibroblast growth factor. Science, 271, 1116-1120 (1996).
34. Olson, S. T. and Bjork, I.: Regulation of thrombin activity by antithrombin and heparin. Semin. Thromb. Hemost., 20, 373-409 (1994).
35. Pye, D. A., Vives, R. R., Turnbull, J. E., Hyde, P., and Gallagher, J. T.: Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem., 273, 22936-22942 (1998).
36. Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A. H., and Kimata, K.: Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem., 279, 12346-12354 (2004).
37. Gupta, P., Oegema, T. R., Jr., Brazil, J. J., Dudek, A. Z., Slungaard, A., and Verfaillie, C. M.: Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood, 95, 147-155 (2000).
38. Gupta, P., Oegema, T. R., Jr., Brazil, J. J., Dudek, A. Z., Slungaard, A., and Verfaillie, C. M.: Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood, 92, 4641-4651 (1998).